|
|
|
|
| B-721Mul | Multiple organ tumor tissue array, including pathology grade, TNM, clinical stage, 72 cases/72 cores | | Cores | 72 | Cases | 72 | | Row number | 8 | Column number | 9 | | Core Diameter(mm) | 1.5 | Thickness(µm) | 5.0 | | Tissue Array Type | FFPE | Species | Human | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 60 minutes at 65℃ before the experiment. 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
Ski -Skin Sof -Soft Tissue Per -Peripheral nerve Mus -Muscle Mes -Mesothelium Tes -Testis Pro -Prostate Cer -Cervix Ute -Uterus Ova -Ovary Bre -Breast Spl -Spleen Lym -Lymph nodes Thy -Thymus Adr -Adrenal gland Thy -Thyroid Bla -Bladder Kid -Kidney App -Appendix Pan -Pancreas Gal -Gallbladder Liv -Liver Col -Colon Sma -Small intestine Sto -Stomach Eso -Esophagus Bon -Bone Bon -Bone or extramedullary Lun -Lung Sal -Salivary gland Ton -Tongue Hea -Head and neck Bra -Brain |
Malignant (*) Malignant (I) Malignant (IA) Malignant (IB) Malignant (II) Malignant (IIA) Malignant (IIB) Malignant (III) Malignant (IIIA) Malignant (IIIB) Malignant (IV) |
|
|
TISSUE ARRAYS B-721Mul |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
A | | | | | | | | | | |
B | | | | | | | | | | |
C | | | | | | | | | | |
D | | | | | | | | | | |
E | | | | | | | | | | |
F | | | | | | | | | | |
G | | | | | | | | | | |
H | | | | | | | | | | |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size |
| A1 | 1 | 51 | F | Brain | Oligodendroglioma | * | * | * | Malignant | * |
| A2 | 2 | 42 | F | Brain | Ependymoma | * | * | * | Malignant | * |
| A3 | 3 | 41 | M | Head and neck | Adenocarcinoma | * | T2N0M0 | II | Malignant | 9*4*4 |
| A4 | 4 | 53 | M | Tongue | Squamous cell carcinoma | * | T3N0M0 | III | Malignant | 5.5 |
| A5 | 5 | 24 | F | Salivary gland | Pleomorphic adenoma | * | * | * | Malignant | * |
| A6 | 6 | 49 | M | Salivary gland | Warthin's tumor with necrosis | * | * | * | Malignant | * |
| A7 | 7 | 59 | M | Lung | Adenocarcinoma | * | T2N0M0 | IB | Malignant | 5*2.5*2 |
| A8 | 8 | 56 | M | Lung | Squamous cell carcinoma | * | T3N2M0 | IIIB | Malignant | 7*6*5 |
| A9 | 9 | 42 | F | Lung | Small cell carcinoma | * | T4N1M0 | IIIA | Malignant | * |
| B1 | 10 | 49 | M | Lung | Atypical carcinoid | * | T4N2M0 | IIIB | Malignant | * |
| B2 | 11 | 31 | M | Bone or extramedullary | Multiple myeloma or plasmacytoma | * | * | * | Malignant | 4.5 |
| B3 | 12 | 19 | M | Bone | Osteosarcoma | * | T2N0M0 G3 | IIB | Malignant | * |
| B4 | 13 | 67 | M | Esophagus | Adenocarcinoma | * | * | * | Malignant | * |
| B5 | 14 | 65 | F | Esophagus | Squamous cell carcinoma | * | * | * | Malignant | 4*2.5*1.5 |
| B6 | 15 | 48 | M | Stomach | Adenocarcinoma | * | T3N2M0 | III | Malignant | 5.5*5.0*0.5 |
| B7 | 16 | 60 | F | Stomach | Gastrointestinal stromal tumor (GIST) | * | * | * | Malignant | * |
| B8 | 17 | 56 | F | Small intestine | Adenocarcinoma | * | T3N2M0 | IIIB | Malignant | 8.0 |
| B9 | 18 | 38 | M | Small intestine | Gastrointestinal stromal tumor (GIST) | * | * | * | Malignant | 10*7*5 |
| C1 | 19 | 54 | F | Small intestine | Neuroendocrine carcinoma | * | T3N2M0 | IIIB | Malignant | 7.0 |
| C2 | 20 | 52 | M | Colon | Adenocarcinoma | * | T3N2M0 | IIIB | Malignant | 3*2*0.5 |
| C3 | 21 | 73 | F | Colon | Squamous cell carcinoma | * | T3N2aM0 | IIIB | Malignant | 3*3*0.5cm |
| C4 | 22 | 46 | M | Colon | Neuroendocrine carcinoma | * | T3N1M0 | IIIB | Malignant | 7.0 |
| C5 | 23 | 62 | M | Liver | Cholangiocarcinoma | * | T2aN0M0 | II | Malignant | 6.0 |
| C6 | 24 | 58 | M | Liver | Hepatocellular carcinoma | * | T2N0M0 | II | Malignant | 7*7*6 |
| C7 | 25 | 59 | M | Gallbladder | Adenocarcinoma (grade:2--3) | * | T2N1M0 | IIIB | Malignant | * |
| C8 | 26 | 56 | F | Gallbladder | Adenocarcinoma (grade:3) | * | T3N1M0 | IIIB | Malignant | * |
| C9 | 27 | 58 | M | Pancreas | Islet cell tumor | * | * | * | Malignant | * |
| D1 | 28 | 39 | F | Pancreas | Ductal adenocarcinoma | * | T3N0M0 | IIA | Malignant | 4*3*1 |
| D2 | 29 | 46 | F | Appendix | Carcinoid | * | T2N0M1 | IV | Malignant | * |
| D3 | 30 | 59 | M | Appendix | Adenocarcinoma | * | T2N1M0 | IIIA | Malignant | * |
| D4 | 31 | 54 | F | Kidney | Papillary renal adenoma | * | * | * | Malignant | * |
| D5 | 32 | 71 | F | Kidney | Renal cell carcinoma | * | T2N0M0 | II | Malignant | 4.0 |
| D6 | 33 | 58 | M | Bladder | Squamous cell carcinoma | * | T3N0M0 | III | Malignant | 3*3*2 |
| D7 | 34 | 65 | F | Bladder | Urothelial cell carcinoma | * | T3N0M0 | III | Malignant | 4.5*4.0*2 |
| D8 | 35 | 45 | M | Thyroid | Follicular thyroid cancer | * | T2N0M0 | I | Malignant | * |
| D9 | 36 | 51 | F | Thyroid | Papillary thyroid cancer | * | T3N1M0 | I | Malignant | 3.3*2.8*2.2 |
| E1 | 37 | 17 | F | Adrenal gland | Adenoma | * | * | * | Malignant | 18*10*6.5 |
| E2 | 38 | 50 | M | Adrenal gland | Pheochromocytoma | * | * | * | Malignant | 6*5*5 |
| E3 | 39 | 35 | M | Thymus | Type B3 thymoma | * | * | * | Malignant | * |
| E4 | 40 | 48 | M | Thymus | Thymic carcinoma | * | * | * | Malignant | 8*6*6 |
| E5 | 41 | 40 | F | Lymph nodes | Islet cell tumor | * | * | * | Malignant | 7*4*2.5 |
| E6 | 42 | 17 | M | Lymph nodes | Hodgkin's Lymphoma | * | * | * | Malignant | * |
| E7 | 43 | 44 | M | Lymph nodes | Mantle cell lymphoma | * | * | * | Malignant | 4*6 |
| E8 | 44 | 59 | M | Lymph nodes | Follicular lymphoma | * | * | * | Malignant | * |
| E9 | 45 | 30 | M | Lymph nodes | T cell lymphoma | * | * | * | Malignant | * |
| F1 | 46 | 60 | M | Spleen | Diffuse large B cell lymphoma | * | * | * | Malignant | * |
| F2 | 47 | 35 | M | Spleen | Angiosarcoma | * | * | * | Malignant | * |
| F3 | 48 | 72 | F | Breast | Invasive ductal carcinoma | * | * | * | Malignant | * |
| F4 | 49 | 41 | F | Breast | Invasive lobular carcinoma | * | * | * | Malignant | * |
| F5 | 50 | 84 | F | Ovary | Granular cell tumor | * | T1aN0M0 | IA | Malignant | 10*6*0.8 |
| F6 | 51 | 45 | F | Ovary | Serous carcinoma | * | T1aN0M0 | IA | Malignant | * |
| F7 | 52 | 63 | F | Uterus | Clear cell carcinoma with necrosis | * | T3bN1M0 | IIIB | Malignant | 6*5*3 |
| F8 | 53 | 53 | F | Uterus | Endometrioid adenocarcinoma | * | T1bN0M0 | IB | Malignant | 5.0*4.5*1.0 |
| F9 | 54 | 48 | F | Uterus | Uterine leiomyosarcoma | * | T2N1M0 | IIIB | Malignant | 9*9*7 |
| G1 | 55 | 41 | F | Cervix | Adenocarcinoma | * | T1aN0M0 | IA | Malignant | 5*4*3 |
| G2 | 56 | 76 | F | Cervix | Squamous cell carcinoma | * | T2N0M0 | II | Malignant | 4*3*2.5 |
| G3 | 57 | 73 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score:4+4) | * | T2aN0M0 | I | Malignant | 4*3.5*3 |
| G4 | 58 | 69 | M | Prostate | Adenocarcinoma (Gleason grade:1, Gleason score:2+1) | * | T3N0M0 | III | Malignant | 4*3*2 |
| G5 | 59 | 21 | M | Testis | Embryonal carcinoma | * | T1N0M0 | I | Malignant | * |
| G6 | 60 | 50 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant | 4.0 |
| G7 | 61 | 38 | F | Mesothelium | Mesothelioma | * | * | * | Malignant | 14*10*2 |
| G8 | 62 | F | 34 | Mesothelium | Pleural solitary fibrous tumor | * | * | * | Malignant | * |
| G9 | 63 | 20 | F | Muscle | Alveolar rhabdomyosarcoma | * | T2N0M0 G4 | IIIB | Malignant | 8*5*5 |
| H1 | 64 | 55 | M | Muscle | Myxoma | * | * | * | Malignant | * |
| H2 | 65 | 40 | F | Muscle | Myxoliposarcoma | * | T2aN0M0 G2 | IIB | Malignant | 5.0 |
| H3 | 66 | 43 | F | Muscle | Myxofibrosarcoma | * | T1bN0M0 | IIA | Malignant | 5.0 |
| H4 | 67 | 55 | F | Peripheral nerve | Neurofibrosarcoma | * | * | * | Malignant | * |
| H5 | 68 | 61 | F | Peripheral nerve | Schwannoma | * | * | * | Malignant | * |
| H6 | 69 | 76 | M | Soft Tissue | Angiosarcoma | * | * | * | Malignant | * |
| H7 | 70 | 42 | M | Soft Tissue | Liposarcoma | * | T1bN0M0 | IIA | Malignant | 4.0 |
| H8 | 71 | 55 | M | Skin | Basal cell carcinoma | * | T2N0M0 | II | Malignant | * |
| H9 | 72 | 68 | M | Skin | Invasive melanoma | * | * | * | Malignant | * | | Tissue Marker |
|
|
